HomeDC4 • FRA
add
DexCom Inc
Nakaraang pagsara
€62.42
Sakop ng araw
€64.03 - €71.42
Sakop ng taon
€52.00 - €120.94
Market cap
32.00B USD
Average na Volume
68.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Investing.com
10 oras ang nakalipas
DexCom shares rise as Canaccord Genuity lifts price target to $106
16.17%
1.06%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.11B | 7.64% |
Gastos sa pagpapatakbo | 466.90M | 6.19% |
Net na kita | 151.70M | -40.81% |
Net profit margin | 13.62 | -45.04% |
Kita sa bawat share | 0.45 | -10.00% |
EBITDA | 246.70M | -8.43% |
Aktuwal na % ng binabayarang buwis | 28.21% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.58B | -5.31% |
Kabuuang asset | 6.48B | 3.51% |
Kabuuang sagutin | 4.38B | 4.43% |
Kabuuang equity | 2.10B | — |
Natitirang share | 390.77M | — |
Presyo para makapag-book | 11.60 | — |
Return on assets | 7.36% | — |
Return on capital | 10.19% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 151.70M | -40.81% |
Cash mula sa mga operasyon | 301.40M | 125.60% |
Cash mula sa pag-invest | -303.70M | -173.20% |
Cash mula sa financing | -1.60M | 99.75% |
Net change in cash | -15.10M | 80.47% |
Malayang cash flow | 143.20M | 354.35% |
Tungkol
DexCom, Inc. is an American healthcare company that develops, manufactures, produces, and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland. Wikipedia
Itinatag
1999
Headquarters
Website
Mga Empleyado
10,250
